Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MULTINATIONAL Retrospective Chart Review Study to Assess the Characteristics, Treatment Outcomes and Resource Use Among Adult Patients Hospitalised for Community-Acquired Pneumonia (CAP) or Complicated Skin and Soft Tissue Infections (cSSTI) Treated With Zinforo (REGISTERED) (Ceftaroline Fosamil) in a Usual Care Setting

NCT04198571 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT04198571
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04198571 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MULTINATIONAL Retrospective Chart Review Study to Assess the Characteristics, Treatment Outcomes and Resource Use Among Adult Patients Hospitalised for Community-Acquired Pneumonia (CAP) or Complicated Skin and Soft Tissue Infections (cSSTI) Treated With Zinforo (REGISTERED) (Ceftaroline Fosamil) in a Usual Care Setting
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
May 17, 2020
Completion date
August 30, 2021
Enrollment
317 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

community acquired pneumonia, complicated skin and soft tissue infection